Picture of GlobeStar Therapeutics logo

GSTC GlobeStar Therapeutics Balance Sheet

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Annual balance sheet for GlobeStar Therapeutics, fiscal year end - September 30th, USD millions except per share, conversion factor applied.

2019
September 30th
2020
September 30th
2021
September 30th
2022
September 30th
2023
September 30th
Period Length:
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Cash and Equivalents
Cash and Short Term Investments0.10.0810.0060.0060
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets0.1410.0890.0060.010
Net Property, Plant And Equipment0.0010.0010
Net Intangible Assets
Long Term Investments
Total Assets0.1420.090.0060.010
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities0.8280.7490.7321.21.43
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities0.8280.7490.7321.21.43
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity-0.685-0.659-0.726-1.19-1.43
Total Liabilities & Shareholders' Equity0.1420.090.0060.010
Total Common Shares Outstanding
Total Preferred Shares Outstanding
0